Calcium channel autoantibodies in Lambert-Eaton myasthenic syndromeLEYS, K; LANG, B; VINCENT, A et al.Lancet (British edition). 1989, Vol 2, Num 8671, issn 0140-6736, 1107 [1 p.]Article

AAEE miniminograph #33: electrodiagnostic approach to defects of neuromuscular transmissionKEESEY, J. C.Muscle & nerve. 1989, Vol 12, Num 8, pp 613-626, issn 0148-639X, 14 p.Article

The Lambert-Eaton myasthenic syndrome: a review of 50 casesO'NEILL, J. H; MURRAY, N. M. F; NEWSOM-DAVIS, J et al.Brain. 1988, Vol 3, Num 3, pp 577-596, issn 0006-8950Article

Autoantibodies bind solubilized calcium channel-ω-conotoxin complexes from small cell lung carcinoma : a diagnostic aid for Lambert-Eaton myasthenic syndromeLENNON, V. A; LAMBERT, E. H.Mayo Clinic proceedings. 1989, Vol 64, Num 12, pp 1498-1504, issn 0025-6196, 7 p.Article

Lambert-Eaton myasthenic syndrome associated with thymitisWARREN, N. M; BENNETT, M; LAI, M et al.Neurology. 2005, Vol 64, Num 1, pp 168-169, issn 0028-3878, 2 p.Article

Carcinome pulmonaire à petites cellules révélé par un syndrone de Lambert-Eaton avec syndrome sec et dystrhyroïdie: hypothèses physiopathogéniques = Pulmonary small cell carcinoma revealed by a Lambert-Eaton sysndrome with Sjögren syndrome and dysthyroïdy: physiopathogenesisLABROUSSE, J. L; LEGRAND, M. F; ARLET-SUAU, E et al.La Semaine des hôpitaux de Paris. 1990, Vol 66, Num 4, pp 161-163, issn 0037-1777, 3 p.Article

Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody : adverse effect of calcium antagonist diltiazemUENO, S; HARA, Y.Journal of neurology, neurosurgery and psychiatry. 1992, Vol 55, Num 5, pp 409-410, issn 0022-3050Conference Paper

Paradoxical lide elevation with sustained upgaze : a sign of Lambert-Eaton syndromeBREEN, L. A; GUTMANN, L; BRICK, J. F et al.Muscle & nerve. 1991, Vol 14, Num 9, pp 863-866, issn 0148-639XArticle

Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndromeCHAUDHRY, V; WATSON, D. F; BIRD, S. J et al.Muscle & nerve. 1991, Vol 14, Num 12, pp 1227-1230, issn 0148-639XArticle

SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndromeSABATER, L; TITULAER, M; SAIZ, A et al.Neurology. 2008, Vol 70, Num 12, pp 924-928, issn 0028-3878, 5 p.Article

Le complexe multimérique d'exocytose: interaction avec les canaux calcium potentiel-dépendant et implications physiopathologiques = The multimeric exocytotic complex: interaction with voltage-gated calcium ceannels and physiopathological implicationsEl Far, Oussama; Seagar, M.1994, 115 p.Thesis

Pathophysiology of Myasthenia gravis and Lambert-Eaton syndromeMASELLI, R. A.Neurologic clinics. 1994, Vol 12, Num 2, pp 285-303, issn 0733-8619Article

Síndrome de Eaton-Lambert = Syndrome de Eaton-Lambert = Eaton-Lambert syndromeURIBE, C. S; MUNOZ, A; NAVARRO, R et al.AMC. Acta médica colombiana. 1988, Vol 13, Num 1, pp 44-46, issn 0120-2448Article

The Lambert-Eaton myasthenic syndromeELRINGTON, G.Palliative medicine. 1992, Vol 6, Num 1, pp 9-17, issn 0269-2163Article

Lambert-Eaton syndrome : antigen-antibody interaction and calcium current inhibition in chromaffin cellsVIGLIONE, M. P; CREUTZ, C. E; KIM, Y. I et al.Muscle & nerve. 1992, Vol 15, Num 12, pp 1325-1333, issn 0148-639XArticle

Myasthenic (Eaton-Lambert) syndrome in association with and indolent non-Hodgkin's lymphomaLIESVELD, J. L; STERN, A; ROSENTHAL, S. N et al.New York State journal of medicine. 1991, Vol 91, Num 1, pp 29-30, issn 0028-7628Article

The intermittent myasthenic syndrome : combination of myasthenia and Lamber-Eaton type myasthenic syndromeSANADZE, A. G.Žurnal nevropatologii i psihiatrii im. S.S. Korsakova. 1991, Vol 91, Num 9, pp 93-97, issn 0044-4588Article

The use of rituximab in myasthenia gravis and Lambert—Eaton myasthenic syndromeMADDISON, Paul; MCCONVILLE, John; FARRUGIA, Maria Elena et al.Journal of neurology, neurosurgery and psychiatry. 2011, Vol 82, Num 6, pp 673-675, issn 0022-3050, 3 p.Article

Lambert-Eaton myasthenic syndromePETTY, Richard.Practical neurology (Print). 2007, Vol 7, Num 4, pp 265-267, issn 1474-7758, 3 p.Article

Lambert-Eaton Myasthenic SyndromeNEWSOM-DAVIS, J.Revue neurologique (Paris). 2004, Vol 160, Num 2, pp 177-180, issn 0035-3787, 4 p.Conference Paper

Données électrophysiologiques dans les syndromes myasthéniformes de type Lambert-Eaton : à propos d'une série de 23 casBADY, B; TRUFFERT, A; VIAL, C et al.Neurophysiologie clinique (Paris). 1992, Vol 22, Num 1, pp 27-39, issn 0987-7053Article

3,4-diaminopyridine in the treatment of Lambert-Eaton myasthenic syndromeMCEVOY, K. M; WINDEBANK, A. J; DAUBE, J. R et al.The New England journal of medicine. 1989, Vol 321, Num 23, pp 1567-1571, issn 0028-4793Article

The Lambert-Eaton myasthenic syndromeSANDERS, Donald B.Advances in neurology. 2002, Vol 88, pp 189-201, issn 0091-3952, 13 p.Article

Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndromeOH, S. J; KIM, D. E; KURUOGLU, R et al.Muscle & nerve. 1996, Vol 19, Num 7, pp 903-906, issn 0148-639XArticle

Specificity of autoantibodies react with ω-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndromeSUENAGA, A; SHIRABE, S; NAKAMURA, T et al.Muscle & nerve. 1996, Vol 19, Num 9, pp 1166-1168, issn 0148-639XConference Paper